Department of Plastic and Cosmetic Reconstructive Surgery, Henri Mondor Hospital, Créteil, France.
Aesthet Surg J. 2021 Jun 14;41(7):NP854-NP865. doi: 10.1093/asj/sjab061.
Many therapeutic options are currently available for facial skin rejuvenation, but little evidence exists about the efficacy of combining such procedures.
The aim of this study was to assess and investigate the synergistic effect of hyaluronic acid (HA) and autologous platelet-rich plasma (a-PRP) injections on facial skin rejuvenation.
For this randomized controlled prospective study, 93 eligible patients were enrolled and randomized into 3 intervention groups to undergo a series of 3 treatment sessions with either a-PRP, HA, or a mixture of a-PRP and HA (Cellular Matrix; Regen Lab) injected into facial cheeks.
A total of 93 patients were included. Treatment with Cellular Matrix led to a very significant improvement in the overall facial appearance compared with treatment with a-PRP or HA alone (P < 0.0001). Participants treated with Cellular Matrix showed a 20%, 24%, and 17% increase in FACE-Q score at 1, 3, and 6 months posttreatment, respectively. For the HA group, the improvement in FACE-Q score was 12%, 11%, and 6% at 1, 3, and 6 months posttreatment, respectively, whereas for the a-PRP group the improvement was 9%, 11%, and 8% at 1, 3, and 6 months posttreatment, respectively. Biophysical measurements showed significantly improved skin elasticity for the Cellular Matrix group compared with the groups receiving a-PRP or HA alone. No serious adverse events were reported.
Combining a-PRP and HA seems to be a promising treatment for facial rejuvenation with a highly significant improvement in facial appearance and skin elasticity compared with a-PRP or HA alone.
目前有许多治疗方案可用于面部皮肤年轻化,但关于联合使用这些方法的疗效证据有限。
本研究旨在评估和研究透明质酸(HA)和自体富血小板血浆(a-PRP)注射联合对面部皮肤年轻化的协同作用。
这项随机对照前瞻性研究纳入了 93 名符合条件的患者,并将其随机分为 3 个干预组,分别接受 a-PRP、HA 或 a-PRP 和 HA(细胞基质;Regen Lab)混合物注射到面颊。
共纳入 93 例患者。与单独使用 a-PRP 或 HA 相比,使用细胞基质治疗可使整体面部外观得到非常显著的改善(P<0.0001)。接受细胞基质治疗的患者在治疗后 1、3 和 6 个月时,FACE-Q 评分分别增加了 20%、24%和 17%。HA 组在治疗后 1、3 和 6 个月时,FACE-Q 评分的改善分别为 12%、11%和 6%,而 a-PRP 组在治疗后 1、3 和 6 个月时,FACE-Q 评分的改善分别为 9%、11%和 8%。生物物理测量显示,与单独接受 a-PRP 或 HA 治疗的组相比,细胞基质组的皮肤弹性显著改善。未报告严重不良事件。
与单独使用 a-PRP 或 HA 相比,联合使用 a-PRP 和 HA 似乎是一种有前途的面部年轻化治疗方法,可显著改善面部外观和皮肤弹性。